A carregar...
The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life
PURPOSE: The aim of this study was to examine what personally mattered to 24 patients who received immuno-oncology (IO) therapy for stage IV non-small cell lung cancer (NSCLC), as well as their families and friends, to understand how they evaluated their cancer treatments and the determinants of the...
Na minha lista:
| Publicado no: | J Cancer Surviv |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7256093/ https://ncbi.nlm.nih.gov/pubmed/31950409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11764-020-00853-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|